BSX (STOCKS)
Boston Scientific Corp.
$52.800000
+1.380000 (+2.68%)
Prev close: $51.420000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael F. Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $79,566.32M
- Employees
- 53,000
- P/E (TTM)
- 20.85
- P/B (TTM)
- 2.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
19
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.86 | $0.84 | +0.0246 | +2.94% |
|
Mar 2026 (Q1)
|
$0.80 | $0.79 | +0.0055 | +0.69% |
|
Dec 2025 (Q4)
|
$0.80 | $0.79 | +0.0127 | +1.61% |
|
Sep 2025 (Q3)
|
$0.75 | $0.72 | +0.0293 | +4.07% |
Financial Statements
| Revenues | $21.00B |
| Benefits Costs and Expenses | $17.14B |
| Cost Of Revenue | $6.32B |
| Costs And Expenses | $17.14B |
| Gross Profit | $14.68B |
| Operating Expenses | $10.53B |
| Selling, General, and Administrative Expenses | $7.16B |
| Other Operating Expenses | $3.37B |
| Operating Income/Loss | $4.15B |
| Income/Loss From Continuing Operations After Tax | $3.67B |
| Income/Loss From Continuing Operations Before Tax | $3.86B |
| Income Tax Expense/Benefit | $192.00M |
| Interest Expense, Operating | $363.00M |
| Net Income/Loss | $3.67B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$6.00M |
| Net Income/Loss Attributable To Parent | $3.68B |
| Net Income/Loss Available To Common Stockholders, Basic | $3.68B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.49 |
| Diluted Earnings Per Share | $2.47 |
| Basic Average Shares | 4,437,600,000 |
| Diluted Average Shares | 4,465,800,000 |
| Assets | $45.22B |
| Current Assets | $7.97B |
| Inventory | $3.24B |
| Other Current Assets | $4.74B |
| Noncurrent Assets | $37.24B |
| Fixed Assets | $4.13B |
| Intangible Assets | $6.92B |
| Other Non-current Assets | $26.20B |
| Liabilities | $20.04B |
| Current Liabilities | $6.43B |
| Accounts Payable | $1.23B |
| Other Current Liabilities | $5.20B |
| Noncurrent Liabilities | $13.62B |
| Equity | $25.17B |
| Equity Attributable To Noncontrolling Interest | $242.00M |
| Equity Attributable To Parent | $24.93B |
| Liabilities And Equity | $45.22B |
| Net Cash Flow From Operating Activities | $4.53B |
| Net Cash Flow From Operating Activities, Continuing | $4.53B |
| Net Cash Flow From Investing Activities | -$3.56B |
| Net Cash Flow From Investing Activities, Continuing | -$3.56B |
| Net Cash Flow From Financing Activities | -$958.00M |
| Net Cash Flow From Financing Activities, Continuing | -$958.00M |
| Exchange Gains/Losses | $2.00M |
| Net Cash Flow | $12.00M |
| Net Cash Flow, Continuing | $10.00M |
| Comprehensive Income/Loss | $4.10B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Comprehensive Income/Loss Attributable To Parent | $4.09B |
| Other Comprehensive Income/Loss | $431.00M |